MapLight Therapeutics Stock Price, News & Analysis
MPLT
NASDAQ
Company Description
Welcome to the overview page for MapLight Therapeutics (MPLT), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$20.07
+0.65%
+0.13
Last updated: December 19, 2025 at 11:17
-
Performance 1 year
$891.1M
43.6M
Latest News
SEC Filings
No SEC filings available for MapLight Therapeutics.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
JUL
01
July 1, 2026 - December 31, 2026
Clinical
ZEPHYR Phase 2 topline
Topline readout for ML-007C-MA (ZEPHYR) Phase 2 in schizophrenia.
JUL
01
July 1, 2026 - December 31, 2026
Clinical
IRIS Phase 2 topline
Topline readout for ML-004 (IRIS) Phase 2 in ASD; enrollment ~160.
JUL
01
July 1, 2026 - December 31, 2026
Clinical
ML-021 IND studies complete
Expected completion of IND-enabling studies for ML-021.
JUL
01
July 1, 2027 - December 31, 2027
Clinical
VISTA Phase 2 topline
Topline readout for VISTA Phase 2 in Alzheimer's disease psychosis.
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of MapLight Therapeutics (MPLT)?
The current stock price of MapLight Therapeutics (MPLT) is $19.94 as of December 18, 2025.
What is the market cap of MapLight Therapeutics (MPLT)?
The market cap of MapLight Therapeutics (MPLT) is approximately 891.1M. Learn more about what market capitalization means .